2014
DOI: 10.1016/j.vaccine.2014.01.062
|View full text |Cite
|
Sign up to set email alerts
|

Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
61
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 58 publications
(73 citation statements)
references
References 29 publications
1
61
1
Order By: Relevance
“…Intrapartum antibiotic prophylaxis would reduce the incidence of early-onset GBS infection by 65%, while also reducing the severity of late-onset disease (Ko et al, 2010). A GBS vaccine is likely to be the most effective preventive strategy, both in pregnant women and newborns (Kim et al, 2014). A GBS polysaccharide-protein conjugate vaccine has completed phase two of a trial in South Africa, and has been shown to prevent both early-and late-onset infection.…”
Section: Discussionmentioning
confidence: 99%
“…Intrapartum antibiotic prophylaxis would reduce the incidence of early-onset GBS infection by 65%, while also reducing the severity of late-onset disease (Ko et al, 2010). A GBS vaccine is likely to be the most effective preventive strategy, both in pregnant women and newborns (Kim et al, 2014). A GBS polysaccharide-protein conjugate vaccine has completed phase two of a trial in South Africa, and has been shown to prevent both early-and late-onset infection.…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, as a consequence of vaccinations in older age, teenage girls will not be covered by the program of vaccinations. Therefore, some authors propose a combination of GBS vaccination with the alreadyused prophylactic procedures recommended by CDC as the most effective in terms of health and costs [31].…”
Section: Discussionmentioning
confidence: 99%
“…A decision-analytic model based on South African data concluded that immunization alone would substantially reduce the burden of infant GBS disease in South Africa and would be very cost-effective by WHO guidelines 167 .…”
Section: F Cost-effectiveness Of Immunizationmentioning
confidence: 99%